News Releases

Mallinckrodt plc to Report First Quarter Results on Thursday, February 6, 2014

DUBLIN--(BUSINESS WIRE)--Jan. 7, 2014--
Mallinckrodt
plc (NYSE: MNK) will report fiscal first quarter 2014 results on
February 6, 2014. The company will hold a conference call for investors
beginning at 8:30am U.S. Eastern Time. The call can be accessed in three
ways.

By telephone: For both “listen-only” participants and those who wish
to take part in the question-and-answer portion of the call, the
telephone dial-in number in the U.S. is 866-318-8614. For participants
outside the U.S., the dial-in number is 617-399-5133. The access code
for all callers is 81312057.

Through an audio replay: A replay of the call will be available
beginning at 12:30pm U.S. Eastern Time on February 6, 2014, and ending
at 11:59pm U.S. Eastern Time on February 13, 2014. The dial-in number
for U.S. participants is 888-286-8010. For participants outside the
U.S., the replay dial-in number is 617- 801-6888. The replay access
code for all callers is 83253336.

ABOUT MALLINCKRODT:

Mallinckrodt is a global specialty pharmaceutical and medical imaging
business that develops, manufactures, markets and distributes specialty
pharmaceutical products and medical imaging agents. The company’s
Specialty Pharmaceuticals segment includes branded and generic drugs and
active pharmaceutical ingredients, and the Global Medical Imaging
segment includes contrast media and nuclear imaging agents. Mallinckrodt
has approximately 5,500 employees worldwide and a commercial presence in
roughly 70 countries. The company’s fiscal 2013 revenue totaled $2.2
billion. To learn more about Mallinckrodt, visit www.mallinckrodt.com.